C0016017||fibrinolysis
C1536220||ST-segment elevation myocardial infarction
C4291682||current guidelines
C0087111||treatment
C1536220||ST-segment elevation myocardial infarction
C1536220||ST-segment elevation myocardial infarction
C0016017||fibrinolysis
C0035124||reperfusion therapy
C0018795||cardiac catheterisation
C0016017||fibrinolysis
C1444656||indicated
C1710136||southwestern
C0017480||Germany
C1532297||emergency primary percutaneous coronary intervention
C1536220||ST-segment elevation myocardial infarction
C0016017||fibrinolysis
C0256103||plasminogen activator reteplase
C0031831||physicians
C0087111||treatment
C0009566||complications
C0019994||hospital
C0035363||retrospectively studied
C1457887||symptoms
C0582446||medical contact
C0016017||fibrinolysis
C0520248||mandated
C2882099||inferior STEMI
C1515021||subgroup
C0009566||complications
C0021308||infarction
C2735050||prehospital
C0036980||cardiogenic shock
C0009566||complications
C0243095||manageable
C1306577||died
C0019994||hospital
C0024348||lysis
C0879626||adverse effects
C0854375||mucosal haemorrhages
C0863090||mild allergic skin reactions
C0018795||cardiac catheterisation
C0022877||laboratory
C0016017||fibrinolysis
C1536220||ST-segment elevation myocardial infarction
C0031831||physicians
C1623258||ECG
C0024348||lysis
C0087111||therapy
C0475309||cardiac centres